Ovid Therapeutics (OVID) FCF Margin (QoQ) (2020 - 2025)
Ovid Therapeutics (OVID) FCF Margin (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 827,182.00 |
| Sep 30, 2025 | -963,982.00 |
| Jun 30, 2025 | 783,084.00 |
| Mar 31, 2025 | 522,652.00 |
| Dec 31, 2024 | -445,964.00 |
| Sep 30, 2024 | -18,226.00 |
| Jun 30, 2024 | 279,485.00 |
| Mar 31, 2024 | -284,984.00 |
| Dec 31, 2023 | 79,020.00 |
| Sep 30, 2023 | 638,981.00 |
| Jun 30, 2023 | 275,539.00 |
| Mar 31, 2023 | 171,299.00 |
| Dec 31, 2022 | 9.43 Mn |
| Mar 31, 2021 | 33,474.00 |
| Dec 31, 2020 | -23,601.00 |